Galecto, Inc.
General ticker "GLTO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.5M (TTM average)
Galecto, Inc. follows the US Stock Market performance with the rate: 30.2%.
Estimated limits based on current volatility of 19.9%: low 19.18$, high 21.58$
Factors to consider:
- Total employees count: 13 (-71.1%) as of 2023
- Top business risk factors: Labor/talent shortage/retention, Operational and conduct risks, Disruption to business operations, Failure to realize cost savings, Inadequate sales and distribution capabilities
- Current price 139.8% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.68$, 9.55$]
- 2025-12-31 to 2026-12-31 estimated range: [1.92$, 6.67$]
Financial Metrics affecting the GLTO estimates:
- Positive: with PPE of -0.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -332.59 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry earnings per price (median), % of -16.34 <= 0
- Positive: Shareholder equity ratio, % of 92.41 > 63.39
Short-term GLTO quotes
Long-term GLTO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $61.21MM | $39.91MM | $22.26MM |
| Operating Income | $-61.21MM | $-39.91MM | $-22.26MM |
| Non-Operating Income | $-0.42MM | $1.56MM | $0.86MM |
| R&D Expense | $48.21MM | $23.77MM | $10.79MM |
| Income(Loss) | $-61.62MM | $-38.35MM | $-21.40MM |
| Taxes | $0.00MM | $0.00MM | $0.04MM |
| Profit(Loss)* | $-61.62MM | $-38.35MM | $-21.44MM |
| Stockholders Equity | $61.75MM | $32.33MM | $15.83MM |
| Assets | $73.19MM | $38.23MM | $17.13MM |
| Operating Cash Flow | $-42.93MM | $-36.91MM | $-18.62MM |
| Capital expenditure | $0.20MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $12.38MM | $22.33MM | $11.65MM |
| Financing Cash Flow | $0.51MM | $2.88MM | $0.32MM |
| Earnings Per Share** | $-60.63 | $-36.08 | $-18.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.